About Vascular Solutions (NASDAQ:VASC)
Vascular Solutions, Inc. is a medical device company focused on bringing clinically advanced solutions to the market for treating coronary and peripheral vascular disease. The Company's product line consists of devices and services that are sold to interventional cardiologists, interventional radiologists, electrophysiologists and vein practices around the world. Its products include GuideLiner catheters, Pronto catheters, Vein catheter reprocessing, Micro-introducer kits, Hemostatic patches, Radial access products, Langston catheters and D-Stat Flowable hemostat. The Company's product portfolio includes a spectrum of over 90 products consisting of approximately 900 stock keeping units (SKUs) covering an array of blood clotting devices, extraction catheters, access catheters, guide extension catheters, micro-introducer kits, guidewires, snare and retrieval devices, a reprocessing service for radiofrequency catheters and a laser and procedure kits for the treatment of varicose veins.
Industry, Sector and Symbol
Sub-IndustryHealth Care Supplies
Trailing P/E RatioN/A
Forward P/E RatioN/A
Sales & Book Value
Price / SalesN/A
Price / CashN/A
Price / BookN/A
EPS (Most Recent Fiscal Year)N/A
Return on Equity15.78%
Return on Assets14.30%
Vascular Solutions (NASDAQ:VASC) Frequently Asked Questions
What is Vascular Solutions' stock symbol?
Vascular Solutions trades on the NASDAQ under the ticker symbol "VASC."
How were Vascular Solutions' earnings last quarter?
Vascular Solutions, Inc. (NASDAQ:VASC) released its quarterly earnings data on Monday, July, 25th. The medical device company reported $0.33 EPS for the quarter, topping analysts' consensus estimates of $0.30 by $0.03. The medical device company had revenue of $41.20 million for the quarter, compared to the consensus estimate of $41.40 million. Vascular Solutions had a net margin of 13.02% and a return on equity of 15.78%. The firm's revenue was up 9.7% on a year-over-year basis. During the same quarter in the previous year, the firm earned $0.29 earnings per share. View Vascular Solutions' Earnings History.
Has Vascular Solutions been receiving favorable news coverage?
Press coverage about VASC stock has trended somewhat positive this week, Accern Sentiment reports. Accern rates the sentiment of media coverage by monitoring more than 20 million blog and news sources in real-time. Accern ranks coverage of public companies on a scale of negative one to one, with scores nearest to one being the most favorable. Vascular Solutions earned a coverage optimism score of 0.15 on Accern's scale. They also gave news articles about the medical device company an impact score of 46.31 out of 100, indicating that recent media coverage is somewhat unlikely to have an effect on the company's share price in the immediate future.
How do I buy shares of Vascular Solutions?
Shares of VASC can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.
What is Vascular Solutions' stock price today?
One share of VASC stock can currently be purchased for approximately $56.00.
How can I contact Vascular Solutions?
Vascular Solutions' mailing address is 6464 Sycamore Ct N, MAPLE GROVE, MN 55369-6032, United States. The medical device company can be reached via phone at +1-763-6564300.
MarketBeat Community Rating for Vascular Solutions (VASC)MarketBeat's community ratings are surveys of what our community members think about Vascular Solutions and other stocks. Vote "Outperform" if you believe VASC will outperform the S&P 500 over the long term. Vote "Underperform" if you believe VASC will underperform the S&P 500 over the long term. You may vote once every thirty days.